An assessment of thiethylperazine (Torecan) in the control of radiation-induced nausea and vomiting.

doi:10.1016/S0009-9260(68)80072-8

Paper

An assessment of thiethylperazine (Torecan) in the control of radiation-induced nausea and vomiting.

Published 1968 · K. Sicher, T. Backhouse

Clinical radiology

Q2 SJR score

6

Citations

2

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCT

Study Snapshot

Thiethylperazine (Torecan) effectively reduces radiation-induced nausea and vomiting in patients undergoing abdominal and pelvic radiotherapy compared to pyridoxine.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

An assessment of thiethylperazine (Torecan) in the control of radiation-induced nausea and vomiting.

References

Citations